Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 5, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	14,584	7,200	8,494	5,597	3,419	502
Market Cap Growth	77.14%	-15.23%	51.75%	63.72%	580.90%	-
Enterprise Value	10,297	2,500	2,824	5,021	1,886	-
Last Close Price	20.97	10.09	10.54	7.38	4.94	9.78
PE Ratio	-	-	1.95	-	-	-
PS Ratio	717.42	247.81	259.64	177.52	61.84	21.10
PB Ratio	3.32	1.39	1.32	3.48	1.66	0.24
P/TBV Ratio	3.34	1.54	1.42	5.53	2.06	0.28
EV/Sales Ratio	506.54	86.05	86.33	159.25	34.11	-
Debt / Equity Ratio	0.02	0.02	0.01	0.30	0.14	0.12
Asset Turnover	0.00	0.01	0.01	0.01	0.02	0.01
Quick Ratio	32.77	32.71	24.35	6.29	11.21	9.39
Current Ratio	33.71	33.47	25.24	6.60	11.64	9.99
Return on Equity (ROE)	-17.36%	-12.54%	112.87%	-48.46%	-44.82%	-43.17%
Return on Assets (ROA)	-12.43%	-10.73%	-10.14%	-20.33%	-20.26%	-11.71%
Return on Capital (ROIC)	-13.29%	-11.52%	-11.34%	-22.80%	-22.54%	-12.91%
Return on Capital Employed (ROCE)	-22.70%	-20.60%	-11.20%	-38.20%	-34.90%	-20.00%
Earnings Yield	-2.56%	-2.39%	51.20%	-18.03%	-24.72%	-161.17%
FCF Yield	-5.38%	-11.72%	-9.03%	-15.29%	-20.33%	-111.12%
Buyback Yield / Dilution	14.52%	12.71%	-16.59%	-6.43%	-6.30%	-187.64%

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q